A Study to Evaluate the Effect of IV Doses of Rivipansel on Subjects With Renal Impairment and in Healthy Subjects

Completed · Phase 1

Conditions studied: Renal Impairment, Healthy

In brief

The purpose of this study is to determine the effect of renal impairment on rivipansel.

Key facts

Study ID

NCT02813798

Run by

GlycoMimetics Incorporated

People needed

28

Starts

2016-06-01

Expected to finish

2018-02-01

Last updated by the study team

2020-06-18

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Female subjects of non-childbearing potential or male subjects
• Body Mass Index (BMI) of 17.5 to 40.0 kg/m2
• Stable renal function

You may not qualify if…

• A positive urine drug screen for illicit drugs
• Treatment with an investigational drug within 30 days of the dose of study medication
• Pregnant females, breastfeeding female subjects and male subjects with partners currently pregnant
• Use of herbal supplements in the 28 days prior to the dose of study medication
• Blood donation (excluding plasma donation) of approximately 1 pint or more within 56 days prior to study medication
• Requiring dialysis

Where it is running

• Anaheim Clinical Trials, LLC — Anaheim, California, United States
• Avail Clinical Research, LLC — DeLand, Florida, United States
• Orlando Clinical Research Center — Orlando, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.